Cargando…
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management
Autores principales: | Giustozzi, Michela, Vedovati, Maria Cristina, Agnelli, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580525/ https://www.ncbi.nlm.nih.gov/pubmed/33127217 http://dx.doi.org/10.1016/j.ejim.2020.10.018 |
Ejemplares similares
-
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis
por: Vedovati, Maria Cristina, et al.
Publicado: (2022) -
Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022) -
Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence
por: Palazzuoli, Alberto, et al.
Publicado: (2021) -
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020) -
Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study
por: Giustozzi, Michela, et al.
Publicado: (2021)